Pacira Biosciences
PCRX
Pacira Biosciences (PCRX) Fails to deliver data
Key failure to deliver metrics for Pacira Biosciences :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $1.59 M
- Last 3 months FTD volume: $1.93 M
- Last year FTD volume: $4.86 M
Failures to deliver for Pacira Biosciences (PCRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Pacira Biosciences (PCRX) - since 2013
Volume in USD (price x number of shares), data since 2013Pacira Biosciences (PCRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.93 M | -36.68% |
| 2023 | $3.06 M | -75.8% |
| 2022 | $12.64 M | -33.52% |
| 2021 | $19.02 M | 259.47% |
| 2020 | $5.29 M | -60.29% |
| 2019 | $13.32 M | 131.9% |
| 2018 | $5.74 M | -82.84% |
| 2017 | $33.49 M | -32.79% |
| 2016 | $49.83 M | 2.28% |
| 2015 | $48.72 M | -65.81% |
| 2014 | $0.14 B | 805.18% |
| 2013 | $15.74 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Zogenix ZGNX | N/A | $54.53 M | 🇺🇸 USA |
 Omeros Corporation OMER | $2.58 M | $20 M | 🇺🇸 USA |
 Heron Therapeutics HRTX | $1.71 M | $11.62 M | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.04 M | $2.53 M | 🇺🇸 USA |